As of 2025-09-15, the Relative Valuation of Exagen Inc (XGN) is (12.43) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.74 USD, the upside of Exagen Inc based on Relative Valuation is -227.6%.
The range of the Relative Valuation is (10.79) - (13.94) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.0x - 18.1x | 15.9x |
| Forward P/E multiples | 11.9x - 18.1x | 16.3x |
| Fair Price | (10.79) - (13.94) | (12.43) |
| Upside | -210.8% - -243.1% | -227.6% |
| Date | P/E |
| 2025-09-12 | -12.62 |
| 2025-09-11 | -12.96 |
| 2025-09-10 | -12.48 |
| 2025-09-09 | -12.70 |
| 2025-09-08 | -12.71 |
| 2025-09-05 | -12.53 |
| 2025-09-04 | -12.74 |
| 2025-09-03 | -12.54 |
| 2025-09-02 | -12.45 |
| 2025-08-29 | -12.78 |
| 2025-08-28 | -12.62 |
| 2025-08-27 | -12.37 |
| 2025-08-26 | -12.83 |
| 2025-08-25 | -12.76 |
| 2025-08-22 | -13.09 |
| 2025-08-21 | -12.93 |
| 2025-08-20 | -12.75 |
| 2025-08-19 | -12.50 |
| 2025-08-18 | -12.63 |
| 2025-08-15 | -12.30 |
| 2025-08-14 | -12.11 |
| 2025-08-13 | -12.53 |
| 2025-08-12 | -12.39 |
| 2025-08-11 | -12.15 |
| 2025-08-08 | -11.92 |
| 2025-08-07 | -11.65 |
| 2025-08-06 | -11.54 |
| 2025-08-05 | -11.49 |
| 2025-08-04 | -11.47 |
| 2025-08-01 | -11.18 |
| 2025-07-31 | -10.88 |
| 2025-07-30 | -11.18 |
| 2025-07-29 | -10.95 |
| 2025-07-28 | -9.57 |
| 2025-07-25 | -9.42 |
| 2025-07-24 | -9.35 |
| 2025-07-23 | -9.48 |
| 2025-07-22 | -8.99 |
| 2025-07-21 | -9.03 |
| 2025-07-18 | -9.07 |
| 2025-07-17 | -9.30 |
| 2025-07-16 | -9.07 |
| 2025-07-15 | -8.78 |
| 2025-07-14 | -9.16 |
| 2025-07-11 | -9.06 |
| 2025-07-10 | -9.07 |
| 2025-07-09 | -8.85 |
| 2025-07-08 | -9.00 |
| 2025-07-07 | -9.02 |
| 2025-07-03 | -9.13 |